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Abstract 
Background  
Since 2013, local authorities in England have been responsible for commissioning 
preventative public health interventions. The aim of this systematic review was to 
support commissioning by collating published data on economic evaluations and 
modelling of local authority commissioned public health preventative interventions in 
the UK.  
Methods  
Following the PRISMA protocol, we searched for economic evaluations of 
preventative intervention studies in four different areas: overweight and obesity, 
physical inactivity, alcohol and illicit drugs use and smoking cessation. The 
systematic review identified studies between January 1994 and February 2015, 
using five databases. We synthesised the studies to identify the key methods and 
examined results of the economic evaluations. 
Results  
The majority of the evaluations related to cost-effectiveness, rather than cost-benefit 
analyses or cost-utility analyses. These analyses found preventative interventions to 
be cost effective, though the context of the interventions differed between the 
studies. 
Conclusions  
Preventative public health interventions in general are cost-effective. There is a need 
for further studies to support justification of continued and/or increased funding for 
public health interventions. There is much variation between the types of 
economically evaluated preventative interventions in our review. Broader studies 
incorporating different contexts may help support funding for local authority-
sponsored public health initiatives. 
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Introduction  
Public health has traditionally had a prominent role in healthcare delivery in the UK. 
With devolution of public health from the National Health Service (NHS) to local 
governments, public health budgets are reducing year-on-year1. Therefore it is 
important to evaluate the economic benefits of public health commissioned 
prevention and lifestyle programmes for improving health, including preventing 
longer-term morbidity and mortality. Interventions for overweight and obesity, 
physical inactivity, alcohol and illicit drugs use and smoking cessation consume 
much of public health resources and are commonly associated with many chronic 
diseases.  
The King’s Fund and the National Institute for Health and Care Excellence (NICE) 
both emphasise the need for evidence of cost-effectiveness of public health 
interventions.2,3 Return on Investment (ROI) has been used broadly in the NHS and 
related organisations to encompass a range of measures and is expressed in 
monetary terms, referring to financial return on investment. Cost-benefit analysis 
(CBA) is expressed in monetary terms and can consider who has been impacted by 
investment in an intervention.4,5 Cost-effectiveness analysis (CEA) can be used to 
decide which intervention or model to use. Cost-consequence analysis (CCA) 
measures what other benefits, other than the desired outcome, may occur or be 
reduced, based on a particular investment. Cost utility analysis (CUA) expresses 
benefits in terms of Quality-adjusted Life Years (QaLYs).5 
Individual ROI tools for physical activity, alcohol and tobacco control have been 
published by NICE.6 These tools enable selection of local area, types of services for 
investment and expected uptake of such services.   
The Public Health Department at the Kent County Council (KCC) is exploring ways 
to demonstrate the combined adjusted impact and ROI of key preventative 
programmes with reference to NICE recommendations.7 This work will contribute 
towards local service planning and transformation work such as Delivering the 5 
Year Forward View.8 A key challenge is estimating the potential reduction in health 
care demand in a defined local population, taking into account a variety of health and 
social risk factors, for which nationally available tools appear not sensitive enough to 
perform.  
A 2013 NICE report found that the majority of public health interventions were a 
good use of public money and could be deemed cost-effective.9 A Local Government 
Association paper highlights how important assessing value for money is for local 
authority public health teams and the importance for spending to be justified on cost-
effectiveness evidence.10  
We conducted a systematic review of the literature to collate the types of economic 
evaluations currently published on public health lifestyle and prevention 
programmes. The primary objective was to identify and summarise published studies 
that are economic evaluations or include economic evaluations of public health 
interventions focused on the following areas: overweight and obesity, physical 
inactivity, alcohol and illicit drug use, and smoking cessation.   
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Methodology 
Search strategy 
The literature review and reporting of the review were guided by the PRISMA 
statement and summary of revisions made to the recommendations from the Quality 
of Reporting Meta-analyses (QUORUM) conference.11,12 Broad search categories 
were used to encompass the areas of intervention and types of economic analysis.   
We searched five bibliographic databases: The Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), EMBASE, Health Management Information 
Consortium (HMIC), MEDLINE and PsychINFO. We also searched the Cochrane 
database, as well as published reports of the NICE. We checked reference lists from 
the selected citations, along with reference lists and bibliographies of key 
professional guidelines and reports. Two researchers undertook the searches, with a 
third revisiting the alcohol search with MeSH terms in MEDLINE.  
 
Search terms 
The search terms used are given in Appendix I. 
All of the search terms in the table were combined with: 
AND (economic OR "economic evaluation" OR "economic analysis" OR cost OR 
"cost evaluation" OR "Cost-Benefit Analysis" OR "Economic Models" OR "Cost 
Analysis"). 
 
Inclusion criteria 
English language studies published between January 1994 and February 2015 were 
included in the review if they were carried out in a local authority, primary care or 
community health care setting in the UK.  
Exclusion criteria  
Studies conducted in a hospital and/or acute care setting, screening programmes 
and tertiary level interventions were excluded. Studies conducted outside of the UK 
were also excluded.  
Study selection and data extraction strategy 
After the searches were completed, the results were imported into a citation 
manager, duplicates were removed and the abstracts were screened by one 
researcher. The selected abstracts were then reviewed by a second researcher and 
those excluded were also reviewed to ensure that the two researchers were in 
agreement over selection of articles for full text review. 
Articles selected for full text review were then sourced and reviewed. Researchers 
reviewed each other’s selections and discussed if there was disagreement over 
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inclusion. Where full text was not available, we attempted to contact the 
corresponding author. 
Data extraction and analysis 
Data extraction tables were constructed including relevant information from the 
selected studies for each intervention area. This examined health intervention area, 
study aim/objective, type of economic evaluation, outcome and comment on study 
quality. 
Search results 
Searches were carried out separately for all of the four areas. A total of 27 articles, 
including 7 from the grey literature, were selected for inclusion in the final review. 
Five studies were related to obesity and overweight, 12 to physical inactivity, 1 to 
alcohol and illicit drugs use, and 9 to smoking cessation. 
Table 1 provides a summary of the articles identified at each stage of the literature 
search for the four areas. Two articles were selected for data extraction for 
overweight and obesity, 10 for physical inactivity, 1 for alcohol and illicit drugs use, 
and 7 for smoking cessation. The end of the table shows the number of articles 
selected for data extraction through grey literature searches, three of which were 
added to overweight and obesity, and four added to physical inactivity. 
Table I: Studies of overweight and obesity, physical Inactivity, alcohol and 
iIlicit drugs use and smoking cessation (grey literature searches and article 
selection)  
Search area Search 
results 
[n] 
Unique 
articles 
(duplicates 
removed) 
[n] 
Studies 
selected for 
full text 
review 
[n] 
Articles for 
final 
inclusion and 
data 
extraction 
[n] 
Breastfeeding 352 260 14 1 
Pharmacy 
healthy weight  
20 12 2 0 
 
Healthy weight 
programme 
8 3 0 0 
Young people 
healthy weight 
1339 268 12 1 
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National child 
measurement 
program 
48 27 0 0 
Physical 
inactivity 
894 289 9 10 (with 
additional 
articles 
identified 
through review 
articles) 
Alcohol and 
illicit drugs use 
 
345 169 14 1 
Smoking 
cessation 
245 113 8 7 
Grey literature   16 3  
Overweight 
and obesity 
2 Physical 
inactivity 
0 Alcohol 
2 Smoking 
cessation 
 
. 
 
 
 
Results 
The results are presented in the four public health intervention areas of obesity and 
overweight (and nutrition), physical inactivity, alcohol and illicit drugs use, and 
smoking cessation. We recorded information for public health intervention area, 
study, aim/objective, type of economic evaluation, outcome and comment on study 
quality. 
Table II shows the number of studies in each of the four areas for the different types 
of economic evaluation: return on investment, cost-benefit analysis, cost utility 
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analysis, cost-effectiveness analysis, and cost-consequence analysis. Appendix II 
shows the results of each evaluation, listed by author and title/part title. This paper 
does not critically appraise the quality of the economic evaluations undertaken. 
 
Overweight, obesity and nutrition  
All the five studies selected covered cost-effectiveness analysis.13-17 One of these 
studies also covered cost-consequence analysis/17Two were predictive tools for the 
costs of implementing guidance on lifestyle weight management services for the 
overweight and obese in England.13,14 Three compared different intervention models: 
care for childhood obesity, interventions to promote breastfeeding, and costs to the 
healthcare system of babies who are breastfed versus those who are formula 
fed.15,16,17 Two of the five studies focussed on breastfeeding.15,17 The other three 
emphasised obesity; one in adults13 and two in children and young people.14,16 
 
Physical inactivity  
Economic evaluation was often a secondary objective of an effectiveness 
intervention study. There was a large variety of physical inactivity interventions 
evaluated. Interventions included:  
 Motivational interviewing to ‘boost’ physical activity levels  
 Exercise referral systems  
 Providing free access to council run gyms  
 Physical activity classes  
 Campaigns, including leisure centre based campaigns  
 Advice  
 Pedometer studies  
 Brief interventions  
 Cycling/walking activities  
 
The majority of physical inactivity economic evaluations were cost-effectiveness 
analyses.18-24,  One report presented a simple return on investment analysis.25 One 
evaluation was a combination of a cost-utility analysis and a cost-consequence 
analysis.26 Another was a cost-effectiveness analysis combined with a cost-benefit 
analysis.27 Two focused on cost utility analysis.28,29  
 
Alcohol and illicit drugs use 
Only one study30 of alcohol and illicit drugs use met the inclusion criteria for this area. 
Economic evaluation was the primary objective for this cost effectiveness and cost 
consequences study, with a comment that little research outside the United States 
has been published in this area. No return on investment articles in the area of 
alcohol in primary or community health care were specific to the UK.  
 
Investigations into four treatment interventions took place in residential and 
community treatment settings in the Godrey study.30 Specialist inpatient and 
residential rehabilitation were investigated in residential settings.  Methadone 
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maintenance and methadone reduction were investigated in community settings. 
Costs and consequences were measured in terms of units of resources consumed 
and valued in terms of long-term opportunity costs. Consequences measured 
included drug possession, dealing and acquisitive crime related to drug use. The 
data showed clear economic benefits to treating drug misusers in England. 
 
Smoking cessation 
As with physical inactivity, the economic evaluation was often the secondary 
objective of an effectiveness study of a smoking cessation intervention. The types of 
smoking interventions being studied included:  
 Changing attitudes to smoking amongst high risk individuals  
 Behavioural support provided by either groups or pharmacies  
 Nicotine Replacement Therapies  
 Cut Down To Quit interventions  
 
The majority of economic evaluations for smoking cessation were cost effectiveness 
analyses.31-38 One study was a cost utility analysis.39 Some of the cost effectiveness 
analyses included economic models.35,36,37  While the majority of smoking cessation 
services were found to be cost-effective, level of cost-effectiveness varied amongst 
the different studies included. For example, cost-effectiveness sometimes depended 
on the age of participants.38 
 
Types of Economic Evaluations Used (Table II) 
Two studies used return on investment. One study used cost-benefit analysis. 
Twenty-one studies used cost-effectiveness analysis. Four studies used cost-
consequence analysis. Four studies used more than one economic evaluation to 
compare an intervention or interventions.  
 
 
Table II: Type of economic evaluation 
 
Type of 
economic  
evaluation 
ROI Cost- 
Benefit 
Analysis 
(CBA) 
Cost 
Utility 
Analysis 
(CUA 
Cost- 
Effectiveness 
Analysis  
(CEA) 
Cost- 
Conse-
quence 
Analysis 
(CCA) 
Overweight, 
obesity 
and nutrition 
0 0 0 
5 13-17 (1 also included 
CCA) 
117 (also 
included 
CEA) 
Physical 
inactivity 1 
25 
1 27 (also 
included 
CEA) 
3 26,28,29 (1 
also included 
CCA) 
9 18-24 (1 also included 
CCA and 1 also 
included CBA) 
1 26 (also 
included 
CUA) 
Alcohol and  
illicit drugs 
0 0 0 
130 (also included 
CCA) 
130 (also 
included 
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use CEA) 
Smoking 
cessation 
0 0 1 39 8 21-34,35-38 0 
 
 
 
Discussion  
Main finding of this study  
This systematic review highlights a diversity of economic evaluations in public health 
interventions. Our analysis showed that the interventions were dissimilar. The results, 
alongside more comprehensive tools such as the NICE return on investment models, 
demonstrate evidence to support the case for local authority commissioned public 
health preventative interventions.  
The majority of the economic evaluations related to cost-effectiveness. These 
evaluations found preventative interventions to be cost-effective. Some of the 
evaluations were economic models or modelling tools, rather than studies of cost-
effectiveness. These included the NICE tools where specific criteria is entered to 
predict the costs; for example, implementing NICE guidance to support 
Commissioning lifestyle weight management programmes for children and young 
people. The NICE physical activity return on investment tool is another example. 
While the majority of smoking cessation services were found to be cost-effective, 
cost-effectiveness varied amongst the different studies included. The cost-
effectiveness of the different physical inactivity interventions also varied by type of 
economic evaluation. 
Economic evaluation was a secondary objective of the physical inactivity and 
smoking cessation studies. Three of the five overweight and obesity studies were 
NICE reports, meaning that there were only two other studies analysed: one that 
looked at the cost effectiveness of breastfeeding compared to formula feeding and 
one that focused on an intervention to prevent obesity in young people. Different 
types of smoking cessation interventions were the subject of the economic 
evaluations we reviewed. Sensitivity analyses influenced the findings of some of the 
studies. For example, Stevens29 found that cost-effectiveness could be increased if 
uptake was increased. 
 
 
What is already known on this topic 
Brousselle and colleagues40 suggest that public health interventions are complex 
and context-sensitive. Intangible benefits, such as wellbeing, can be difficult to 
quantify. Buck2 notes that public health may show improvement following local 
authority expenditure in areas not specific to public health (e.g., increased bike 
paths).  
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What this study adds  
This review shows that the number of UK-based, non-acute economic evaluation 
studies in the public health intervention areas of overweight and obesity, physical 
inactivity, alcohol and illicit drugs use, and smoking cessation is very small. There is 
a need for further studies, specific to the areas we explored, along with broader 
studies that cover more than one intervention area and/or population.40,41  
While this systematic review supports the view that local authority-funded 
preventative public health interventions are cost-effective, there is much variation 
between types of interventions economically evaluated. An increase in the number of 
non-acute economic evaluation studies specific to interventions for obesity, physical 
inactivity, alcohol and illicit drugs use may improve statistical support for the 
reliability of those interventions, particularly if the interventions and populations are 
similar. There is also a need for studies involving broad approaches to public health 
interventions. 
There are contradictory views on the usefulness of comparing broad approaches to 
economic evaluation39, versus a cautious approach with respect to context-
sensitivity.40 Broader studies emphasizing cost-effectiveness of interventions for 
different populations in a variety of settings may help support funding for local 
authority-sponsored public health initiatives. When we have enough studies available 
to conduct a meta-analysis, we can make widespread recommendations to 
commissioners with more confidence.  While Brousselle40 argues that public health 
commissioners should not draw general conclusions about the cost-effectiveness of 
public health interventions, Pokhrel41 advocates for increasing the number of 
research studies that compare results on interventions in different contexts. 
Furthermore, it is recommended that interventions be compared across different 
countries on a large scale to support broad generalisation. Rutter notes that research 
activities are prone towards identifying simple health outcomes, rather than complex 
or population-level outcomes. A broad range of methods for intervention research 
and evidence synthesis is necessary to inform effective policies.42  
 
 
Limitations of this study 
A limitation of this review is that we conducted separate searches for each of the four 
areas, without a fifth, broader search that may have included one or more areas. A 
broader search may have found articles that described an economic evaluation of an 
intervention as part of a larger topic. Increasingly, cost-effectiveness analyses are 
taking this broad approach, meaning more interventions can be compared against 
each other. Cost per life year saved, or cost per QALY saved is often measured in 
these broader approaches.5 This increasingly broad approach indicates that the lack 
of heterogeneity in our results may not be a limitation. 
 
By limiting the included articles to studies based in the UK, we may have missed 
evaluations of types of interventions that are carried out in the UK, but were based 
elsewhere in the published study.  By limiting inclusion criteria to local authority-
commissioned interventions, we may have missed out on economic studies that 
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were commissioned by other bodies, but could be commissioned by local authorities. 
The Comment on Study Quality column for our data extraction tables was intended 
to provide inspiration for possible comparison of studies, rather than a rigorous 
assessment of each study quality. 
 
Conclusions 
This systematic review explores economic evaluations related to local public health 
interventions in the UK. Most of the evaluations focussed on cost-effectiveness, with 
preventative interventions shown to be cost effective. Further studies are needed, 
specific to economic evaluation of local authority-commissioned interventions and to 
consider accuracy of broad versus narrow approaches to evaluating cost-
effectiveness. 
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Appendix I: Search categories and search terms  
Intervention 
Area 
Key 
interventions 
Search terms 
Overweight and 
obesity 
Breastfeeding 
– uptake 
promotion  
 
Pharmacies - 
healthy weight 
programme 
 
Healthy living/ 
healthy weight 
programmes 
 
Young people 
healthy weight 
programme 
 
 
National child 
measurement 
programme 
(breastfeeding OR breastfeeding AND 
promotion) 
 
 
(Pharmacies AND (Obesity OR Overweight))  
 
 
(obesity OR overweight)  AND ("weight 
reduction programs" OR "healthy people 
programs")  
  
(overweight OR obesity)  AND (adolescent 
OR "young person" OR child) 
(overweight OR obesity).  
 
 
 (overweight OR obesity) AND “school 
health” 
Physical activity Physical 
activity 
promotion 
("physical activity" OR exercise* NOT rehab* 
NOT physiotherapy).  
 
Alcohol and illicit 
drugs use 
Primary and 
secondary 
prevention of 
substance 
misuse  
 
 
 
 
 
 
 
 
 
 
Primary and 
secondary 
prevention of 
excess alcohol 
consumption 
 
(“Early intervention” OR “education 
program*” OR “prevention” OR “prevention 
program*” OR “education campaign “OR 
“awareness” OR “awareness campaign” OR 
“awareness program*” OR “intervention 
program*” OR “brief intervention” OR “brief 
advice” or “advice” OR “IBA” OR “guidance” 
AND 
"Substance-related disorders" OR "drug-
related disorders" OR "drug use prevention" 
OR "drug use control" OR "drug misuse" OR 
"drug abuse" OR "drug abuse prevention" 
OR "substance abuse" OR "substance 
abuse prevention” or ”substance abuse 
education program*” OR  “drug abuse 
education program*” )  
(("Primary Health Care"[Mesh]) OR 
"Community Health Services"[Mesh]) AND 
"Drinking Behavior/prevention and 
control"[Majr] AND Great Britain[Mesh]  
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Smoking 
cessation 
Smoking 
cessation and 
reduction 
("Smoking Cessation" OR "smoking 
cessation methods" OR "smoking 
prevention" OR "smoking control")  
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Appendix II: Summary Results of the Evaluations and Evaluation Tools 
 
Author(s)/Title or Part Title   Summary/Result 
NICE 2014 PH53 Overweight and obese 
adults13 
Modelling showed that even a small amount of 
weight loss is cost effective, but only if it is 
maintained long term on a lower weight 
trajectory. It was difficult to draw conclusions 
about why some programmes were more 
effective than others, or about the effect of 
specific components. Group programmes in 
general tend to be more cost effective.   
NICE 2013. Costing Report: Managing 
overweight and obesity among children and 
young people14 
The following impacts have been defined as 
significant: 1) More than 300 people are 
estimated to be affected by the 
recommendations (equivalent to 1 person per 
170,000) 2) Initial costing work indicates that the 
national cost is more than £1 million (equivalent 
to £2000 per 100,000 population). 
Ball TM, Wright AL. Health care costs of 
formula-feeding15 
In the first year of life, after adjusting for 
confounders, there were 2033 excess office 
visits, 212 excess days of hospitalization, and 
609 excess prescriptions for these three 
illnesses per 1000 never-breastfed infants 
compared with 1000 infants exclusively breastfed 
for at least 3 months. These 
additional health care services cost the 
managed care health system between $331 and 
$475 per never-breastfed infant during the first 
year of life. 
Hollinghurst S, Hunt LP, Banks J, et al. Cost 
and effectiveness16 
Cost and outcome data were available for 143 
children in total. Cost per child was £1749 (SD 
£243) in the Mandometer® group, £301 (£76) in 
the primary care group, and £263 (£88) and 
£209 (£81) in the hospital groups. Mean 
reduction in BMI SDS was 0.40 (0.35), 0.17 
(0.26), 0.15 (0.25) and 0.14 (0.32), respectively. 
Intensive management using Mandometer® was 
effective but costly (£432 per 0.1 reduction in 
BMI SDS) compared to conventional care (range 
£153-£173). A total of 26% children receiving 
conventional care achieved a clinically 
meaningful reduction in BMI SDS; however, use 
of Mandometer® training may be justified in 
children not responding to conventional lifestyle 
interventions. 
Jacklin P, Retsa P, Dougherty M, Kwan I. NICE 
Maternal and Child Nutrition Programme17 
Peer support which achieves a relatively high 
increase in breastfeeding rates actually saves 
the NHS money in the long run, because levels 
of hospitalisation of babies drop, breastfed 
babies grow up into healthier children and adults, 
fewer women develop breast cancer, and less 
has to be spent on infant formula. This is 
achieved at an estimated 20 percentage point 
increase in breastfeeding initiation. The point at 
which expenditure on breastfeeding support is 
unjustified in competition with other demands on 
NHS resources could be evaluated in terms of 
the expenditure per QALY gained. NICE 
currently adopts a threshold between £20,000 
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and £30,000 for this purpose. It is estimated that 
this is achieved when there is an increase in 
initiation rates of about 15 percentage points. 
Goyder E, Hind D, Breckon J, et al, A 
randomised controlled trial and cost-
effectiveness evaluation18 
Although some individuals do find a community-
based, brief MI 'booster' intervention supportive, 
the low levels of recruitment and retention and 
the lack of impact on objectively measured 
physical activity levels in those with adequate 
outcome data suggest that it is unlikely to 
represent a clinically effective or cost-effective 
intervention for the maintenance of recently 
acquired physical activity increases in deprived 
middle-aged urban populations. 
 Murphy SM, Edwards RT, Williams N, et 
al.. An evaluation of the effectiveness and 
cost effectiveness19 
The National Exercise Referral Scheme  was 
effective in increasing physical activity among 
those referred for CHD risk only. Among mental 
health referrals, NERS did not influence physical 
activity but was associated with reduced anxiety 
and depression. NERS is likely to 
be cost effective with respect to prevailing payer 
thresholds. 
Isaacs AJ, Critchley JA, Tai SS, et al. Exercise 
Evaluation Randomised Trial20 
On cost-effectiveness grounds, assessment and 
advice alone from an exercise specialist may be 
appropriate to initiate action in the first instance. 
Subsidised schemes may be best concentrated 
on patients at higher absolute risk, or with 
specific conditions for which particular 
programmes may be beneficial. Walking appears 
to be as effective as leisure centre classes and is 
cheaper. Efforts should be directed towards 
maintenance of increased activity, with proven 
measures such as telephone support. Further 
research should include an updated meta-
analysis of published exercise interventions 
using the standardised mean difference 
approach. 
Shaw R, Fenwick E, Baker G, et al. 
Pedometers cost buttons21 
Pedometer based walking interventions may be 
considered cost-effective and suitable for 
implementation within the wider community. 
However, several research gaps remain, 
including the importance and impact of the 
researcher/participant relationship, the impact of 
assessment on motivation and effectiveness, 
and the longer term impact on physical and 
mental health, resource utilisation and quality of 
life. 
Stevens W, Hillsdon M, Thorogood M, McArdle 
D. Cost-effectiveness of a primary care based22 
Moderate physical activity can be successfully 
encouraged in previously sedentary men and 
women aged 45-74 through 
a primary care based intervention. The process 
of recruitment was the most important variable 
cost. A high uptake rate would maximise cost-
effectiveness, and sensitivity analysis suggests 
that unit costs could be halved with a more 
effective recruitment strategy. 
Laine J, Kuvaja-Köllner V, Pietilä E, et al.  
Cost-Effectiveness of Population-Level23 
The most efficient interventions to increase 
physical activity were community rail-trails 
($.006/MET-h), pedometers ($.014/MET-h), and 
school health education programs ($.056/MET-
h). 
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NICE. 2014. Physical activity return on 
investment tool. 24 
This tool enables the user to evaluate a portfolio 
of interventions in their geographical area (e.g. 
region, county or local authority) and models the 
economic returns that can be expected in 
different payback timescales.  
NICE. 2013 Costing Report Brief physical 
activity advice in primary care25  
The annual resource impact of implementing the 
recommendations considered in this report is 
uncertain. However, as the recommendations 
aim to support and extend the reach and impact 
of existing stop smoking services, there are 
potential additional costs involved. Organisations 
are advised to assess the resource implications 
at a local level. 
Trueman JP, Anokye NK. Applying economic 
evaluation to public health interventions26 
The incremental cost per QALY of Exercise 
Referral Schemes is £20,876. Based on a cohort 
of 100 000 individuals, CCA estimates cost of 
ERS at £22 million to the healthcare provider and 
£12 million to participants. The benefits of ERS 
include additional 3900 people becoming 
physically active, 51 cases of CHD avoided, 16 
cases of stroke avoided, 86 cases of diabetes 
avoided and a gain of ∼800 QALYs. 
Frew EJ, Bhatti M, Win K, Sitch A, Lyon A, 
Pallan M, Adab P. Cost-effectiveness of a 
community-based physical activity 
programme27 
The societal value placed on the Be 
Active programme was greater than the 
operation cost therefore the Be 
Active physical activity intervention results in a 
net benefit to society. 
Pringle A., Cooke C., Gilson, N., Marsh K., & 
McKenna, J. Cost effectiveness of interventions 
to improve moderate physical-activity28 
Future cost savings to the NHS per intervention 
participant ranged from c£769 to c£4,891. In the 
case of each of the interventions, this saving per 
participant exceeds the implementation cost per 
participant, which ranged from c£55 to c£3,420 
(N = 6940). 
NICE. 2006. Modelling the cost effectiveness of 
physical activity interventions29 
When costs are defined as only including the 
costs of the intervention, all the interventions 
have a cost per QALY gained significantly less 
than £30,000 when compared separately with 
‘usual care’: the cost/QALY gained estimates for 
the interventions reviewed vary from c£20 to 
c£670. When costs are defined to include the 
healthcare costs avoided through avoiding health 
states, all the interventions are dominant when 
compared separately with ‘usual care’. That is, 
they result in an increase in quality of life for 
participants and net costs savings to the health 
service: net costs saved per QALY gained vary 
from c£530 to c£3,150. 
Godfrey C, Stewart,D. Gossop,M. Economic 
analysis of costs and consequences of the 
treatment of drug misuse30 
Crime costs fell by pound 16.1 million during the 
first year, and by pound 11.3 million during the 
second year. Health-care costs were relatively 
small but approximately doubled during the 
course of the study. The ratio 
of consequences to net treatment investment 
varied from 18 : 1 to 9.5 : 1, depending on 
assumptions. This is likely to be a conservative 
estimate of the benefit-cost ratio because many 
potential benefits were not estimated. 
Stevens W, Thorogood M, Kayikki S. Cost-
effectiveness of a community anti-smoking 
campaign31 
The estimated cost-effectiveness of this 
intervention was 105 pound (range 33-391 
pound) per life year gained. Campaigns targeted 
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at groups with high smoking prevalence may be 
more cost-effective than general population 
campaigns 
Bauld L, Boyd KA, Briggs AH, et al. One-year 
outcomes and a cost-effectiveness analysis32 
The group service achieved a higher quit rate 
(6.3%) than the pharmacy service (2.8%) but 
was more intensive and required greater 
overhead costs. The lifetime analysis resulted in 
an incremental cost per QALY of £4,800 for the 
group support and £2,600 for pharmacy one-to-
one counseling. Despite disappointing 1-year 
quit rates, both services were considered to be 
highly cost-effective. 
Parrot S, Godfrey C, Raw M, et al. Guidance 
for Commissioners on the Cost Effectiveness 
[Review]33 
For a typical health authority a comprehensive 
programme of face to face smoking cessation 
interventions could be implemented at an annual 
cost of £331 000. Such a programme is 
estimated to save 1300 life years over a 40 year 
period. In cost effectiveness terms our estimates 
range from £212 to £873 per discounted life year 
gained. 
Wang D, Connock M, Barton P, et al. 'Cut down 
to quit' with nicotine replacement therapies 
[Review]34 
CDTQ is highly cost-effective compared with no 
quit attempt. CDTQ remains cost-effective if 
dilution from abrupt quitting forms a small 
proportion of CDTQ attempts. In an alternative 
analysis in which smokers who switch from an 
abrupt quit to CDTQ retain the success rate of 
abrupt quitters, all forms of CDTQ appear cost-
effective.  
Orme ME, Hogue SL, Kennedy LM, et al. 
Development of the health and economic 
consequences [Modelling tool]35 
The model successfully captures the complexity 
required to model smoking behaviour and 
associated mortality, morbidity, and health care 
costs.  
NICE 2014. Tobacco Return on Investment 
Tool [Modelling tool]36 
The tool will automatically estimate the smoking 
and ex-smoking populations based on up-to-date 
statistics. This population composition is used to 
model the impact of smoking on relevant 
endpoints, taking into account short-, medium- 
and long-term events. 
NICE 2013. Costing Report: Tobacco harm 
reduction37 
Potential costs are likely to vary widely 
depending on: 1) how the recommendations 
are integrated into existing stop smoking 
services 2) the prevalence of smoking among 
different groups of people and the number of 
these people who are likely to access services. 
Organisations are advised to assess the 
resource implications at a local level. 
Stapleton JA, Lowin A, Russell MA. 
Prescription of transdermal nicotine patches38 
If GPs were allowed to 
prescribe transdermal nicotine patches on the 
NHS, for up to 12 weeks, the incremental cost 
per life year saved would be: Pound Sterling 398 
per person younger than 35 years; Pound 
Sterling 345 for those aged 35-44 years; Pound 
Sterling 432 for those aged 45-54 years; and 
Pound Sterling 785 for those aged 55-65 years. 
The low cost per life year saved would make GP 
intervention against smoking a cost-effective life-
saving treatment.  
Crealey GE, McElnay JC, Maguire TA, O'Neill 
C. Costs and effects associated with a 
Our findings indicate that the cost per life-year 
saved when using the Pharmacists Action on 
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community39 Smoking programme ranges from 196.76 pounds 
sterling (Pounds) to 351.45 Pounds for men and 
from 181.35 Pounds to 772.12 Pounds for 
women (1997 values), depending on age. This 
compares favourably with other disease 
prevention medical interventions such as 
screening for hypertension or 
hypercholesterolaemia. 
 
 
